Just imagine if you are the game masters, even if quarter results are good, will you push very high and risk your holder running away and lesser RI/ICPS subscription? If you think public money is peanuts, think again. Hundreds or thousands of retailers can amount to a large combined sum of money.
No need talk about pressing below RI price, that's just common sense where nobody will subscribe when they can buy lower from market.
Hence, holding this counter equates to longer period than you or me originally expected. Most of us expect price will fly once next quarter results are out, but it doesn't seem that way after the latest announcement. The RI/ICPS exercise expected completion timeframe is mid of 2021. Good luck!
I been holding since 2018. I bought the share because of potential busines they run and future profits. To me, bio got huge potential as their business model from farm to mouth which attract me to buy. I believe they can sustain and grow in long term. So i bought it because of business not because of share price drop or goreng :p
This pandamic is unprecendeted event so Bio also didn't expect this in their long term business plan (incurred loss due to MCO restriction). but last year we have seen they got projects in hand. So atleast we know now the management is working to grow their business alternatively and the contract value show us the business model potential already. So just wait and be long term investor (if you are look to groth ypur wealth). Lets the stock do the magic. No one can control the share price. And no one know the future price of the share when it will go to RM1 or RM2. If they know, everybody are rich now ;p
Bio just started seriously their operation in china market last september. I believe more to come (new contracts) in indonesia and other china province. Dont expect a small cap company grow in one week or price go shoot up so much in one day.
So what i going to do now is if the price drop lower, add more portion for long term (margin safety). And buy some for trading portion. If price go higher, sell my trading portion and ride my long term portion. Never bet everything you have.
Well, every business got their risk. The things here how you manage the business risk from retailers perspective since we are investing our money in stock market.
The issue price of the Rights Shares shall be fixed and announced by the Board at a later date before the announcement of the Entitlement Date, after taking into consideration the following:
(i) the rationale for the Proposed Rights Issue of Shares as set out in Section 7.1 of this announcement; (ii) the amount of proceeds that Bioalpha wishes to raise as detailed in Section 8 of this announcement; and
(iii) the theoretical ex-all price of Bioalpha Shares (“TEAP”) based on the 5-day volume weighted average market price of Bioalpha Shares (“5D-VWAP”) up to and including the last trading day prior to the price-fixing date, with the issue price to be at a discount of not more than 20% to the TEAP.
The indicative issue price of RM0.23 per Rights Share is at a discount of RM0.0377 or 14.08% to the TEAP of RM0.2677, calculated based on the 5D-VWAP up to and including the LPD of RM0.2702.
manager777: long term holding mentality is always good, including never all in and your flexible approach to add/trade. However, I've been in Rights Issue before and believe that it is the worst possible method for fund raising (at least to the public).
Also, I always take into consideration the probablity factor in stock market, right now just want to sell and run away at cost or little profit. Possibly will buy back once price drops lower and closer to the RI price (it always does, can research on other counters).
That's my perspective anyway, no right or wrong, cheers and good luck!
... price not fixed .. and will base on 5 days vwap ... and Directors need to fork out $ .. the higher it goes ... retailers will also need to follow Directors/Big Shareholder pay higher $ .. a bit in dilemma? goreng or not goreng? :D
The Board of Directors of Bioalpha Holdings Berhad (“Bioalpha” or “the Company”) wishes to announce that Bioalpha International Sdn. Bhd. (“BISB”), a wholly-owned subsidiary of Bioalpha has on 25 January 2021 entered into a Procurement and Distribution Agreement (“Agreement”) with Shanghai Bukun Trading Co., Ltd (“SBTC”), a wholly-owned subsidiary of Sinopharm (Hainan) Health Industry Co., Ltd (“Sinopharm Hainan”) for the procurement and distribution of vaccines in Malaysia, including but not limited to the Covid-19 vaccine developed by Sinovac Biotech Co., Ltd. (“Sinovac Biotech”), subject to relevant authorities’ approvals which include the National Pharmaceutical Regulatory Agency (“NPRA”). This arrangement has also been endorsed by Sinovac Biotech with regards to the Covid-19 vaccine.
Bioalpha is a OBM { original brand manufacturer} in China, the manufacturing plant is located at Guizhou, China. They have tied up with Yonghui superstores Ltd { a company listed on Shanghai stock exchange} their recent rights issue may be used to fund their latest collaboration on vaccine related business. Just trying to fig out and digest what's happening
The Board of Directors of Bioalpha Holdings Berhad (“Bioalpha” or “the Company”) wishes to announce that Bioalpha International Sdn. Bhd. (“BISB”), a wholly-owned subsidiary of Bioalpha has on 25 January 2021 entered into a Procurement and Distribution Agreement (“Agreement”) with Shanghai Bukun Trading Co., Ltd (“SBTC”), a wholly-owned subsidiary of Sinopharm (Hainan) Health Industry Co., Ltd (“Sinopharm Hainan”) for the procurement and distribution of vaccines in Malaysia, including but not limited to the Covid-19 vaccine developed by Sinovac Biotech Co., Ltd. (“Sinovac Biotech”), subject to relevant authorities’ approvals which include the National Pharmaceutical Regulatory Agency (“NPRA”). This arrangement has also been endorsed by Sinovac Biotech with regards to the Covid-19 vaccine.
look at bintai, totally different field but announce vaccine news can goreng 200%. Bioalpha field very related to vaccine surely will goreng more than that
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
sting79
760 posts
Posted by sting79 > 2021-01-25 12:59 | Report Abuse
Just imagine if you are the game masters, even if quarter results are good, will you push very high and risk your holder running away and lesser RI/ICPS subscription? If you think public money is peanuts, think again. Hundreds or thousands of retailers can amount to a large combined sum of money.
No need talk about pressing below RI price, that's just common sense where nobody will
subscribe when they can buy lower from market.
Hence, holding this counter equates to longer period than you or me originally expected. Most of us expect price will fly once next quarter results are out, but it doesn't seem that way after the latest announcement. The RI/ICPS exercise expected completion timeframe is mid of 2021. Good luck!